Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ross McKinney

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Journal of Clinical Pharmacology|December 20, 2011
Developmental pharmacokinetic changes of Lamivudine in infants and childrenAdriana H Tremoulet, Mina Nikanjam, Tim R Cressey, et al.
AIDS (London, England)|November 5, 2008
Continuous improvement in the immune system of HIV-infected children on prolonged antiretroviral therapyAdriana Weinberg, Ruth Dickover, Paula Britto, et al.
The Hastings Center Report|September 22, 2016
A Conceptual Model for the Translation of Bioethics Research and ScholarshipDebra J H Mathews, D Micah Hester, Jeffrey Kahn, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 1, 2015
HIV-1 Drug Resistance and Second-Line Treatment in Children Randomized to Switch at Low Versus Higher RNA ThresholdsLinda Harrison, Ann Melvin, Susan Fiscus, et al.
The Pediatric Infectious Disease Journal|January 27, 2004
Mutations linked to drug resistance, human immunodeficiency virus type 1 biologic phenotype and their association with disease progression in children receiving nucleoside reverse transcriptase inhibitorsJanet A Englund, Claire Raskino, Cindy Vavro, et al.
The Pediatric Infectious Disease Journal|September 19, 2002
Trends in interventions to reduce perinatal human immunodeficiency virus type 1 transmission in North CarolinaSusan A Fiscus, Adaora A Adimora, Michele L Funk, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|April 22, 2020
Practical Implications of Novel Coronavirus COVID-19 on Hospital Operations, Board Certification, and Medical Education in Surgery in the USAZhi Ven Fong, Motaz Qadan, Ross McKinney, et al.
Journal of Medical Ethics|May 14, 2013
Systematic review and metasummary of attitudes toward research in emergency medical conditionsAlexander T Limkakeng, Lucas Lentini Herling de Oliveira, Tais Moreira, et al.
The Journal of Infectious Diseases|December 28, 2021
Frequent Development of Broadly Neutralizing Antibodies in Early Life in a Large Cohort of Children With Human Immunodeficiency VirusAmanda Lucier, Youyi Fong, Shuk Hang Li, et al.
The Lancet. Infectious Diseases|February 4, 2011
First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children: an open-label, randomised phase 2/3 trial, Abdel Babiker, Hannah Castro nee Green, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Journal of Clinical Pharmacology|December 20, 2011
Developmental pharmacokinetic changes of Lamivudine in infants and childrenAdriana H Tremoulet, Mina Nikanjam, Tim R Cressey, et al.
AIDS (London, England)|November 5, 2008
Continuous improvement in the immune system of HIV-infected children on prolonged antiretroviral therapyAdriana Weinberg, Ruth Dickover, Paula Britto, et al.
The Hastings Center Report|September 22, 2016
A Conceptual Model for the Translation of Bioethics Research and ScholarshipDebra J H Mathews, D Micah Hester, Jeffrey Kahn, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 1, 2015
HIV-1 Drug Resistance and Second-Line Treatment in Children Randomized to Switch at Low Versus Higher RNA ThresholdsLinda Harrison, Ann Melvin, Susan Fiscus, et al.
The Pediatric Infectious Disease Journal|January 27, 2004
Mutations linked to drug resistance, human immunodeficiency virus type 1 biologic phenotype and their association with disease progression in children receiving nucleoside reverse transcriptase inhibitorsJanet A Englund, Claire Raskino, Cindy Vavro, et al.
The Pediatric Infectious Disease Journal|September 19, 2002
Trends in interventions to reduce perinatal human immunodeficiency virus type 1 transmission in North CarolinaSusan A Fiscus, Adaora A Adimora, Michele L Funk, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|April 22, 2020
Practical Implications of Novel Coronavirus COVID-19 on Hospital Operations, Board Certification, and Medical Education in Surgery in the USAZhi Ven Fong, Motaz Qadan, Ross McKinney, et al.
Journal of Medical Ethics|May 14, 2013
Systematic review and metasummary of attitudes toward research in emergency medical conditionsAlexander T Limkakeng, Lucas Lentini Herling de Oliveira, Tais Moreira, et al.
The Journal of Infectious Diseases|December 28, 2021
Frequent Development of Broadly Neutralizing Antibodies in Early Life in a Large Cohort of Children With Human Immunodeficiency VirusAmanda Lucier, Youyi Fong, Shuk Hang Li, et al.
The Lancet. Infectious Diseases|February 4, 2011
First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children: an open-label, randomised phase 2/3 trial, Abdel Babiker, Hannah Castro nee Green, et al.
Pageof 3